New CRISPR-based diagnostic test detects pathogens in blood without amplification
Bioengineering professor and The Grainger College of Engineering's Dean, Rashid Bashir, led a team of researchers in a ...
Skyhawk Therapeutics Presents at Huntington's Disease Youth Organization HDYO International Congress 2025
Skyhawk Therapeutics, Inc., a clinical-stage biotechnology company developing novel small molecule therapies designed to ...
Arizona State Retirement System Increases Stake in Avidity Biosciences, Inc. (NASDAQ:RNA)
Arizona State Retirement System boosted its stake in Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) by 12.2% in the 4th ...
BMO Capital Markets Initiates Coverage on Avidity Biosciences (NASDAQ:RNA)
BMO Capital Markets assumed coverage on shares of Avidity Biosciences (NASDAQ:RNA – Free Report) in a research note issued to ...
Rensselaer News16h
RPI Researchers Aim to Manufacture mRNA More Affordably
Biotechnology researchers at Rensselaer Polytechnic Institute (RPI) are working to further improve mRNA therapeutics, with ...
Tiny ‘microlightning’ flashes inside water droplets may have sparked life on Earth
One famous experiment conducted in 1952 by American chemists Stanley Miller and Harold Urey provided a possible explanation: ...
Biomolecular 'silly putty': High-res imaging of cellular condensates achieved using fluorogen technology
Biomolecular condensates are shifting blobs in our cells that organize cellular matter. They are distinct molecular ...
Scientists unlock key to reviving the 110-year-old Tasmanian Tiger – here’s how
Once considered a lost species, this carnivorous marsupial, officially known as the thylacine, could soon make a comeback ...
Post falsely claims Trump bans Covid-19 mRNA vaccines
Misinformation about vaccines has swirled online since US President Donald Trump appointed Robert F. Kennedy Jr. – who has ...
Korro Bio, Inc.: KRRO-110 Receives Orphan Drug Designation from U.S. FDA for Alpha-1 Antitrypsin Deficiency
Korro Bio, Inc. (Korro) (Nasdaq: KRRO), a clinical-stage biopharmaceutical company focused on developing a new class of genetic medicines based on ...